Bourgeois Yoshioka, Clémence Kiho
Takenaka-Ninagawa, Nana
Goto, Megumi
Miki, Mayuho
Watanabe, Daiki
Yamamoto, Masamichi
Aoyama, Tomoki
Sakurai, Hidetoshi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP13bm0104001, JP23bm1323001, 22ama121050j0002, 20ek0610017h0003)
Japan Society for the Promotion of Science (17J40184)
Article History
Received: 18 December 2023
Accepted: 4 September 2024
First Online: 19 September 2024
Declarations
:
: All animal experiments were performed in compliance with the regulations of the Kyoto University Recombinant DNA Experiment Safety Committee and were approved by the Kyoto University Animal Experiment Committee (“Research on rehabilitation interventions to maximize the therapeutic effect of cell transplantation in a model of refractory muscle disease”, No. 17-81, approved on March 17, 2017; “Experiments to elucidate the pathogenesis mechanisms of DMD mouse model by applying ATP visualization technology”, No. 20-141, approved on October 7, 2020) and by the Committee of Experimental Animal Research of National Cerebral and Cardiovascular Center (“Studies on the dynamics of energy metabolism in mice and rats in vivo”, 21053, 22029, 23018, approved on June 16, 2021). All animal models and experimental procedures conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Generation of human immortalized myoblasts Hu5/KD3 was approved by the Ethics Committee of the National Center for Geriatrics and Gerontology (“Molecular and Cellular Biological Analysis of Tissue repair and Regeneration”, No. 09-01, approved in October, 2009), and was conducted from the human primary myoblasts obtained by biopsy from a 44-year-old woman with informed consent at the Kanagawa Cancer Center Research Institute as described by Wada et al. []. The Hu5/KD3 cells were transferred to Kyoto University by Material Transfer Agreement (OUTBOUND QUICK-MATERIAL TRANSFER AGREEMENT, signed on February 7, 2013).
: Not applicable.
: The authors declare that they have no competing interests.